Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 162,712 shares at $38.17 ($6.2M) on 2020-07-30, disclosed to the SEC on 2020-08-03.
Open-market sale of $6.2M NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.17 | 81,356 | $3.1M | 50.0% |
| 2 | $38.17 | 81,356 | $3.1M | 50.0% |
| Total | $38.17 avg | 162,712 | $6.2M | 100% |
| Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |
| NEO | SELL | 2019-02-28 | $7.1M | — | Filing → |